49,006
edits
(17 intermediate revisions by the same user not shown) | |||
Line 39: | Line 39: | ||
*[[Collagenous gastritis]]. | *[[Collagenous gastritis]]. | ||
This article gives an overview of causes of gastritis. It also deals with ''[[acute gastritis]]'' and the usual ''[[chronic gastritis]]'' without an apparent histologic cause | This article gives an overview of causes of gastritis. It also deals with ''[[acute gastritis]]'' and the usual ''[[chronic gastritis]]'' without an apparent histologic cause. | ||
Other forms of gastritis are dealt with in their own articles. | |||
==General== | ==General== | ||
Line 55: | Line 57: | ||
**Salmonellosis. | **Salmonellosis. | ||
**[[CMV]]. | **[[CMV]]. | ||
**[[EBV]]. | |||
**[[Syphilis]]. | |||
*Endocrine-related: | *Endocrine-related: | ||
**[[Pernicious anemia]]. | **[[Pernicious anemia]]. | ||
Line 72: | Line 76: | ||
*Erythematous. | *Erythematous. | ||
==Microscopic== | |||
*Inflammatory cells - see below. | *Inflammatory cells - see below. | ||
===Acute gastritis=== | |||
*[[AKA]] ''active gastritis''. | *[[AKA]] ''active gastritis''. | ||
Line 81: | Line 85: | ||
*Neutrophils - especially when intraepithelial. | *Neutrophils - especially when intraepithelial. | ||
====Focal active gastritis==== | |||
DDx: | DDx: | ||
#Drugs,<ref>{{Cite journal | last1 = Parfitt | first1 = JR. | last2 = Driman | first2 = DK. | title = Pathological effects of drugs on the gastrointestinal tract: a review. | journal = Hum Pathol | volume = 38 | issue = 4 | pages = 527-36 | month = Apr | year = 2007 | doi = 10.1016/j.humpath.2007.01.014 | PMID = 17367604 }} | #Drugs,<ref>{{Cite journal | last1 = Parfitt | first1 = JR. | last2 = Driman | first2 = DK. | title = Pathological effects of drugs on the gastrointestinal tract: a review. | journal = Hum Pathol | volume = 38 | issue = 4 | pages = 527-36 | month = Apr | year = 2007 | doi = 10.1016/j.humpath.2007.01.014 | PMID = 17367604 }} | ||
Line 88: | Line 92: | ||
#Inflammatory bowel disease. | #Inflammatory bowel disease. | ||
===Chronic gastritis=== | |||
Features: | Features: | ||
*[[Plasma cells]] (in lamina propria). | *[[Plasma cells]] (in lamina propria). | ||
Line 98: | Line 102: | ||
*Approximately 20% of cases with an inflamed cardia will have [[intestinal metaplasia]].<ref name=pmid10566710>{{Cite journal | last1 = Voutilainen | first1 = M. | last2 = Färkkilä | first2 = M. | last3 = Mecklin | first3 = JP. | last4 = Juhola | first4 = M. | last5 = Sipponen | first5 = P. | title = Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group. | journal = Am J Gastroenterol | volume = 94 | issue = 11 | pages = 3175-80 | month = Nov | year = 1999 | doi = 10.1111/j.1572-0241.1999.01513.x | PMID = 10566710 }}</ref> | *Approximately 20% of cases with an inflamed cardia will have [[intestinal metaplasia]].<ref name=pmid10566710>{{Cite journal | last1 = Voutilainen | first1 = M. | last2 = Färkkilä | first2 = M. | last3 = Mecklin | first3 = JP. | last4 = Juhola | first4 = M. | last5 = Sipponen | first5 = P. | title = Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group. | journal = Am J Gastroenterol | volume = 94 | issue = 11 | pages = 3175-80 | month = Nov | year = 1999 | doi = 10.1111/j.1572-0241.1999.01513.x | PMID = 10566710 }}</ref> | ||
====Images==== | |||
<gallery> | <gallery> | ||
Image: Chronic gastritis -- intermed mag.jpg | Moderate chronic gastritis - intermed. mag. (WC) | Image: Chronic gastritis -- intermed mag.jpg | Moderate chronic gastritis - intermed. mag. (WC) | ||
Line 104: | Line 108: | ||
Image: Chronic gastritis -- very high mag.jpg | Moderate chronic gastritis - very high mag. (WC) | Image: Chronic gastritis -- very high mag.jpg | Moderate chronic gastritis - very high mag. (WC) | ||
</gallery> | </gallery> | ||
===Sydney criteria for gastritis=== | |||
A bunch of pathologists in Sydney came-up with criteria... and these were revised in Houston.<ref name=pmid8827022>{{cite journal |author=Dixon MF, Genta RM, Yardley JH, Correa P |title=Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 |journal=Am. J. Surg. Pathol. |volume=20 |issue=10 |pages=1161-81 |year=1996 |month=October |pmid=8827022 |doi= |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0147-5185&volume=20&issue=10&spage=1161}}</ref> | A bunch of pathologists in Sydney came-up with criteria... and these were revised in Houston.<ref name=pmid8827022>{{cite journal |author=Dixon MF, Genta RM, Yardley JH, Correa P |title=Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 |journal=Am. J. Surg. Pathol. |volume=20 |issue=10 |pages=1161-81 |year=1996 |month=October |pmid=8827022 |doi= |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0147-5185&volume=20&issue=10&spage=1161}}</ref> | ||
====Classification==== | |||
Updated Sydney classification:<ref name=pmid8827022/> | Updated Sydney classification:<ref name=pmid8827022/> | ||
{| class="wikitable" | {| class="wikitable" | ||
Line 134: | Line 126: | ||
*''Incisura'' = angular incisure, incisura angularis (Latin) - notched transition point on lesser curvature of the stomach between pylorus and body.<ref>[http://en.wikipedia.org/wiki/Angular_incisure http://en.wikipedia.org/wiki/Angular_incisure]</ref> | *''Incisura'' = angular incisure, incisura angularis (Latin) - notched transition point on lesser curvature of the stomach between pylorus and body.<ref>[http://en.wikipedia.org/wiki/Angular_incisure http://en.wikipedia.org/wiki/Angular_incisure]</ref> | ||
====Severity==== | |||
The Sydney group suggests grading severity with the following language:<ref name=pmid8827022/> | The Sydney group suggests grading severity with the following language:<ref name=pmid8827022/> | ||
*Mild. | *Mild. | ||
Line 166: | Line 158: | ||
|} | |} | ||
==Sign out== | |||
===Minimal chronic inactive=== | |||
<pre> | <pre> | ||
STOMACH, BIOPSY: | STOMACH, BIOPSY: | ||
- BODY AND ANTRAL-TYPE GASTRIC MUCOSA WITH MINIMAL CHRONIC INACTIVE INFLAMMATION. | - BODY AND ANTRAL-TYPE GASTRIC MUCOSA WITH MINIMAL CHRONIC INACTIVE INFLAMMATION. | ||
- NEGATIVE FOR | - NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS. | ||
- NEGATIVE FOR INTESTINAL METAPLASIA. | - NEGATIVE FOR INTESTINAL METAPLASIA. | ||
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. | - NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. | ||
</pre> | </pre> | ||
===Mild chronic inactive=== | |||
<pre> | <pre> | ||
Stomach, Antrum, Biopsy: | Stomach, Antrum, Biopsy: | ||
Line 193: | Line 185: | ||
</pre> | </pre> | ||
====Block letters==== | |||
<pre> | <pre> | ||
STOMACH, BIOPSY: | STOMACH, BIOPSY: | ||
- BODY AND ANTRAL-TYPE GASTRIC MUCOSA WITH MILD CHRONIC INACTIVE INFLAMMATION. | - BODY AND ANTRAL-TYPE GASTRIC MUCOSA WITH MILD CHRONIC INACTIVE INFLAMMATION. | ||
- NEGATIVE FOR | - NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS. | ||
- NEGATIVE FOR INTESTINAL METAPLASIA. | - NEGATIVE FOR INTESTINAL METAPLASIA. | ||
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. | - NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. | ||
Line 207: | Line 199: | ||
- ANTRAL-TYPE GASTRIC MUCOSA WITH MODERATE CHRONIC INACTIVE INFLAMMATION. | - ANTRAL-TYPE GASTRIC MUCOSA WITH MODERATE CHRONIC INACTIVE INFLAMMATION. | ||
- BODY-TYPE GASTRIC MUCOSA WITH MILD CHRONIC INACTIVE INFLAMMATION. | - BODY-TYPE GASTRIC MUCOSA WITH MILD CHRONIC INACTIVE INFLAMMATION. | ||
- NEGATIVE FOR | - NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS. | ||
- NEGATIVE FOR INTESTINAL METAPLASIA. | - NEGATIVE FOR INTESTINAL METAPLASIA. | ||
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. | - NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. | ||
Line 213: | Line 205: | ||
====Moderate chronic active==== | ====Moderate chronic active==== | ||
<pre> | |||
STOMACH, BIOPSY: | |||
- Body and antral-type gastric mucosa with moderate chronic active inflammation. | |||
- NEGATIVE for Helicobacter-like organisms. | |||
- NEGATIVE for intestinal metaplasia. | |||
- NEGATIVE for dysplasia and NEGATIVE for malignancy. | |||
</pre> | |||
=====Block letters===== | |||
<pre> | <pre> | ||
STOMACH, BIOPSY: | STOMACH, BIOPSY: | ||
- BODY AND ANTRAL-TYPE GASTRIC MUCOSA WITH MODERATE CHRONIC ACTIVE INFLAMMATION. | - BODY AND ANTRAL-TYPE GASTRIC MUCOSA WITH MODERATE CHRONIC ACTIVE INFLAMMATION. | ||
- NEGATIVE FOR | - NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS. | ||
- NEGATIVE FOR INTESTINAL METAPLASIA. | - NEGATIVE FOR INTESTINAL METAPLASIA. | ||
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. | - NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. | ||
</pre> | |||
====Severe active==== | |||
<pre> | |||
Stomach, Biopsy: | |||
- Antral-type gastric mucosa with severe chronic active inflammation | |||
with evidence of ulceration (fibrin, necro-inflammatory debris). | |||
- NEGATIVE for Helicobacter-like organisms. | |||
- NEGATIVE for intestinal metaplasia. | |||
- NEGATIVE for dysplasia and NEGATIVE for malignancy. | |||
Comment: | |||
Follow-up is suggested. | |||
</pre> | </pre> | ||
====Sleeve gastrectomy==== | ====Sleeve gastrectomy==== | ||
<pre> | |||
Partial Stomach, Sleeve Gastrectomy: | |||
- Stomach wall with focal mild chronic inactive inflammation of the mucosa. | |||
- NEGATIVE for Helicobacter-like organisms. | |||
- NEGATIVE for intestinal metaplasia. | |||
- NEGATIVE for dysplasia and NEGATIVE for malignancy. | |||
</pre> | |||
=====Alternate===== | |||
<pre> | |||
Partial Stomach, Sleeve Gastrectomy: | |||
- Stomach wall with mild chronic inactive inflammation of the mucosa, otherwise | |||
within normal limits. | |||
</pre> | |||
=====Block letters===== | |||
<pre> | <pre> | ||
STOMACH, GREATER CURVATURE, SLEEVE GASTRECTOMY: | STOMACH, GREATER CURVATURE, SLEEVE GASTRECTOMY: | ||
- STOMACH WALL WITH FOCAL MILD CHRONIC ACTIVE INFLAMMATION OF THE MUCOSA. | - STOMACH WALL WITH FOCAL MILD CHRONIC ACTIVE INFLAMMATION OF THE MUCOSA. | ||
- NEGATIVE FOR | - NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS. | ||
- NEGATIVE FOR INTESTINAL METAPLASIA. | - NEGATIVE FOR INTESTINAL METAPLASIA. | ||
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. | - NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY. |
edits